Preclinical evidence from the Russian research programs in which Epithalon was developed suggests the compound may reduce oxidative damage markers and support cellular longevity pathways beyond telomere maintenance alone
It prevents potential receptor desensitization, allowing your bodys GHK-Cu receptors to maintain full sensitivity
Because IGF-1 influences cellular growth and glucose regulation pathways, dosing should only occur under physician supervision
Thus, it is not surprising that GSH (or the [GSH]/[GSSG] ratio) plays a key role in many diseases including cancer, inflammation, Alzheimer's disease, Parkinson's disease, sickle cell anemia, liver disease, cystic fibrosis, AIDS, heart attack, stroke, and diabetes [4, 6] as well as in aging [79]
These findings are valuable for mechanism, but they cannot substitute for controlled human outcomes